Patient characteristics by outcome
| Characteristic | Statistic/level | Adverse outcome | No adverse outcome | Total |
| Age (years) | N | 15 397 (3.45%) | 430 687 (96.55%) | 446 084 |
| Mean (SD) | 55.1 (18) | 43.2 (17.1) | 43.6 (17.2) | |
| Median (IQR) | 57 (41, 69) | 40 (29, 56) | 41 (29, 57) | |
| Range | 16 to 105 | 16 to 110 | 16 to 110 | |
| Sex | Male | 8328 (54.1%) | 221 350 (51.4%) | 229 678 (51.5%) |
| Female | 7069 (45.9%) | 209 337 (48.6%) | 216 406 (48.5%) | |
| Comorbidities | Asthma/Chronic obstructive pulmonary disease (COPD) | 2694 (17.5%) | 63 345 (14.7%) | 66 039 (14.8%) |
| Other chronic respiratory disease | 76 (0.5%) | 946 (0.2%) | 1022 (0.2%) | |
| Diabetes | 6057 (39.3%) | 72 929 (16.9%) | 78 986 (17.7%) | |
| Hypertension | 6871 (44.6%) | 116 326 (27%) | 123 197 (27.6%) | |
| Immunosuppression (HIV) | 2041 (13.3%) | 75 254 (17.5%) | 77 295 (17.3%) | |
| Heart disease | 5472 (35.5%) | 77 742 (18.1%) | 83 214 (18.7%) | |
| Pregnant | 105 (0.7%) | 2642 (0.6%) | 2747 (0.6%) | |
| Conscious Level | Missing | 652 (4.2%) | 11 826 (2.8%) | 12 478 (2.8%) |
| Alert | 10 861 (70.5%) | 389 797 (90.5%) | 400 658 (89.8%) | |
| Voice | 384 (2.5%) | 5598 (1.3%) | 5982 (1.3%) | |
| Confused | 797 (5.2%) | 16 988 (3.9%) | 17 785 (4%) | |
| Pain | 794 (5.2%) | 3177 (0.7%) | 3971 (0.9%) | |
| Unresponsive | 1909 (12.4%) | 3301 (0.8%) | 5210 (1.2%) | |
| Systolic BP (mm Hg) | Missing | 13 784 (3.2%) | ||
| N | 14 489 | 417 499 | 431 988 | |
| Mean (SD) | 120 (29.5) | 131.2 (25.4) | 131.1 (25.6) | |
| Median (IQR) | 127 (110, 146) | 128 (115, 144) | 128 (115, 144) | |
| Range | 50–289 | 50–300 | 50–300 | |
| Pulse rate (beats/min) | Missing | 13 577 (3%) | ||
| N | 14 552 | 417 955 | 432 507 | |
| Mean (SD) | 99 (23.6) | 93.4 (21) | 93.5 (21.1) | |
| Median (IQR) | 98 (83, 114) | 92 (79, 106) | 92 (79, 107) | |
| Range | 11–300 | 10–300 | 10–300 | |
| Respiratory rate (breaths/min) | Missing | 13 540 (3%) | ||
| N | 14 540 | 418 004 | 432 544 | |
| Mean (SD) | 21.7 (6.5) | 18.5 (4) | 18.6 (4.1) | |
| Median (IQR) | 20 (18, 24) | 18 (16, 20) | 18 (16, 20) | |
| Range | 2–60 | 1–60 | 1–60 | |
| Oxygen saturation | Missing | 27 781 (6.2%) | ||
| N | 14 275 | 404 028 | 418 303 | |
| Mean (SD) | 90.5 (11.5) | 96.3 (5.3) | 96.1 (5.7) | |
| Median (IQR) | 95 (87, 98) | 97 (96, 99) | 97 (95, 99) | |
| Range | 10–100 | 10–100 | 10–100 | |
| Oxygen administration | Missing | 26 704 (6%) | ||
| 1 (air) | 7770 (53.9%) | 377 447 (93.2%) | 385 217 (91.9%) | |
| 2 (40% O2) | 404 (2.8%) | 7767 (1.9%) | 8171 (2%) | |
| 3 (28% O2) | 10 (0.1%) | 304 (0.08%) | 314 (0.1%) | |
| 4 (Nasal prongs) | 1242 (8.6%) | 10 999 (2.7%) | 12 241 (2.9%) | |
| 5 (FM neb) | 38 (0.3%) | 949 (0.2%) | 987 (0.24%) | |
| 6 (rebreather mask) | 1648 (11.4%) | 6514 (1.6%) | 8162 (2%) | |
| 7 (nasal prongs and rebreather mask) | 385 (2.67%) | 996 (0.25%) | 1381 (0.3%) | |
| 8 intubated | 2693 (18.7%) | 0 | 2693 (0.6%) | |
| 9 NIV | 218 (1.5%) | 0 | 218 (0.1%) | |
| Temperature (°C) | Missing | 12 510 (2.8%) | ||
| N | 14 743 | 418 831 | 433 574 | |
| Mean (SD) | 36.4 (1.3) | 36.3 (0.8) | 36.3 (0.8) | |
| Median (IQR) | 36.4 (35.9, 37) | 36.3 (36, 36.7) | 36.3 (36, 36.7) | |
| Range | 25–41.6 | 25–42 | 25–42 | |
| Cough | Missing | 135 488 (30.4%) | ||
| Present | 637 (8.2%) | 12 038 (4%) | 12 675 (4.1%) | |
| Fever | Missing | 135 488 (30.4%) | ||
| Present | 203 (2.6%) | 3998 (1.3%) | 4201 (1.4%) | |
| COVID PCR | Positive | 13 027 (84.6%) | 90 157 (20.9%) | 103 184 (23.1%) |
| Hospital admission | ICU | 2204 (14.3%) | 0 | 2204 (0.5%) |
| Death | Within 30 days contact | 11 142 (72.4%) | 0 | 11 142 (2.5%) |
ICU, intensive care unit.